다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
미국
NASDAQ
Amneal Pharmaceuticals Inc (AMRX)
Amneal Pharmaceuticals Inc (AMRX) 뉴스

AMRX

Amneal Pharmaceuticals (AMRX)

Amneal Pharmaceuticals Inc

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:AMRX

1

일자	시간	출처	헤드라인	심볼	기업
2024/05/21	05:10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/05/17	04:13	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/05/15	05:38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/05/14	05:15	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/05/09	05:46	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/01/25	21:30	GlobeNewswire Inc.	Knight Therapeutics Enters into Exclusive License Agreement with Amneal Pharmaceuticals for IPX203	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/01/10	21:03	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/01/06	06:09	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/01/04	06:36	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:AMRX	Amneal Pharmaceuticals Inc
2024/01/04	06:30	Edgar (US Regulatory)	Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]	NASDAQ:AMRX	Amneal Pharmaceuticals Inc

검색 관련기사 보기:NASDAQ:AMRX

1

European Warrant

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관